Table 3.
Drugs in Development for Treatment of Tuberculosis
| Available | Human Tuberculosis Studies |
|---|---|
| Moxifloxacin | Phase 3 |
| Gatifloxacin | Phase 3 |
| Higher doses of rifapentine | Phase 2 |
| Linezolid | Phase 2 |
| Not Yet Available | |
| Delamanid (OPC-67683) | Phase 3 |
| Bedaquiline (TMC-207) | Phase 2 |
| PA-824 | Phase 2 |
| SQ-109 | Phase 2 |
| PNU-100480 | Phase 2 |